The global Bone Graft Substitute Market is expected to register a CAGR of 6.29% during the forecast period and hit USD 4,408.50 million by 2027.
Bone grafting is a surgical procedure used to operate severely complicated bone fractures. Bone grafts are implantable materials used during a medical process to aid in bone formation, bone healing, and osseous reconstruction. In contrast to autogenous or allogenous bone, a Bone Graft Substitute Market Size can be described as a synthetic, inorganic, or biologically organic combination that can fill bone defects instead.
The global bone graft substitute market size is mainly driven by the rising incidents of road injuries and joint disorders, the development of biocompatible synthetic bone grafts, and increased demand for dental bone graft procedures. However, several factors such as the high costs of surgery and risks and complications arising from bone graft procedures are restraining the growth of the market.
The global bone graft substitute market has been divided based on product type and application.
Based on product type, the market has been segregated into allograft, bone graft, and substitute cell-based matrices. Allografts are further segmented into machine allografts and Demineralized Bone Matrix (DBM). Bone grafts are also further segmented into synthetic bone graft and bone morphogenic proteins.
Based on application, the bone graft substitute market size has been divided into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.
Regional Analysis:
The global bone graft substitute market size, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate with the largest market share due to the high number of orthopedic surgeries, adoption of bone graft substitutes, and the presence of prominent key players. Europe accounted for a substantial share in the global bone graft substitute market. Europe has evolved as a prominent market with the growing awareness about bone graft substitutes and surging healthcare expenses. The region has considerable growth potentials that would help in the expansion of the global market in the coming years. Asia-Pacific is projected to be the fastest-growing region in the bone graft substitute market, mainly due to the presence of evolving economies, such as India, China, and South Korea, and the increasing potential patient population. The market in the Middle East & Africa is also growing dramatically due to the increasing number of research companies and subsidiaries involved in R&D, increasing initiatives taken by the Middle East countries to develop their healthcare infrastructure. Moreover, the growing awareness and demand from the general population for effective orthopedic treatments are likely to favor the market growth.
Key Findings of the Study:
The global bone graft substitute market was valued at USD 2,890.2millionin 2020 and is projected to register a CAGR of6.29% during the assessment period.
The Americas accounted for the largest share of the global market due to the growing awareness and demand for effective orthopedic treatments from the general.
Based on product type, the allograft segment accounted for the largest market share with a value of USD 1,446.8 million in 2020.
Based on application, the spinal fusion segment accounted for the largest market share with a value of USD 915.9million in 2020.
Medtronic Plc (Ireland), AlloSource (US), Zimmer Biomet Holdings Inc. (US), and Stryker (US) are the key market players.
Browse Detailed TOC with COVID-19 Impact Analysis at:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),